Table 1.
Acquired | Genetic | Mixed | ||
---|---|---|---|---|
Medical | Drugs | Behavioural | ||
Age | Oral contraceptives | Obesity | Non-0 blood group | High FVIII |
Major surgery | Postmenopausal hormones | Long-haul travel | Antithrombin deficiency | High VWF |
Neurosurgery | In vitro fertilization | Smoking | Protein C deficiency | High FIX |
Orthopaedic surgery | Chemotherapy | No alcohol | Protein S deficiency | High FXI |
Prostatectomy | Psychotropic drugs | No exercise | Factor V Leiden (rs6025) | High prothrombin |
Malignancy | Thalidomide | Exercise (elderly) | Prothrombin 20210A (rs1799963) | dysfibrinogenaemia |
Trauma | Corticosteroids | Coffee | fibrinogen 10034 T (rs2066865) | Low TFPI |
Prolonged bed rest | Strenuous work (arm thrombosis) | factor XIII val34leu (rs5985) | High PCI | |
Central venous catheter | SERPINC1 (rs2227589) | High fibrinogen | ||
Plaster cast | FXI (rs2289252) | High TAFI | ||
Myeoloproliferative disease | FXI (rs2036914) | Hypofibrinolysis | ||
Heparin induced Thrombocytopenia | GP6 (rs1613662) | Hyperhomocysteinaemia | ||
Hyperthyroid disease | FV (rs4524) | Hypercysteinaemia | ||
Cushing syndrome | HIVEP1 (rs169713) | |||
Arthroscopy | TSPAN15 (rs78707713) | |||
Lupus anticoagulant | SLC44A2 (rs2288904) | |||
ORM1 (rs150611042) |
F factor, VWF von Willebrand factor, GP6 glycoprotein VI Platelet, TFPI tissue factor pathway inhibitor, TAFI thrombin activatable fibrinolysis inhibitor, PCI protein C inihibitor